NASDAQ: COCPCocrystal Pharma Inc Stock Ownership - Who owns Cocrystal Pharma?
Insider buying vs selling
Have Cocrystal Pharma Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Phillip Md Et Al Frost | Director | 2025-11-26 | 1,500 | $1.00 | $1.50kBuy |
| Phillip Md Et Al Frost | Director | 2025-11-26 | 2,500 | $0.99 | $2.48kBuy |
| Phillip Md Et Al Frost | Director | 2025-11-25 | 20,000 | $0.94 | $18.82kBuy |
| Phillip Md Et Al Frost | Director | 2025-10-28 | 359,713 | $1.39 | $500.00kBuy |
| Fred Hassan | Director | 2025-10-28 | 359,713 | $1.39 | $500.00kBuy |
| James Joseph Martin | Co-CEO and CFO | 2025-10-28 | 3,598 | $1.39 | $5.00kBuy |
COCP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when COCP insiders and whales buy or sell their stock.
COCP Shareholders
What type of owners hold Cocrystal Pharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gary Wilcox | 245.84% | 33,887,210 | $35.58M | Insider |
| Opko Health Inc | 135.64% | 18,696,301 | $19.63M | Insider |
| Raymond F. Schinazi | 69.65% | 9,600,078 | $10.08M | Insider |
| Jane Ph D. Hsiao | 64.80% | 8,931,948 | $9.38M | Insider |
| Steven D. Rubin | 52.28% | 7,206,235 | $7.57M | Insider |
| Phillip Md Et Al Frost | 45.54% | 6,276,644 | $6.59M | Insider |
| Fred Hassan | 10.03% | 1,383,009 | $1.45M | Insider |
| Jeffrey A. Meckler | 4.77% | 657,161 | $690.02k | Insider |
| Roger D. Kornberg | 3.95% | 545,095 | $572.35k | Insider |
| Vanguard Group Inc | 1.94% | 268,080 | $281.48k | Institution |
COCP vs Biotech Stocks
Cocrystal Pharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.